Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conditioning Regimens Before Allogeneic Stem Cell Transplant for Hematologic Malignancies and Aplastic Anemia
NCT00003816Phase 3Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Oct 1998
- Primary completion
- Jul 2019
- Modality
- DNA Intercalators/Alkylators, Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of busulfan, cyclophosphamide, antithymocyte globulin rabbit, fludarabine, melphalan in aplastic anemia, hematologic malignancy, sponsored by Roswell Park Comprehensive Cancer Center. Started Oct 1998; status: completed.
02
Drugs
busulfancyclophosphamideantithymocyte globulin rabbitfludarabinemelphalan
03
Conditions
aplastic anemiahematologic malignancy
Beyond the preview
Go deeper on NCT00003816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003816.